N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial.
Lai ZW, Hanczko R, Bonilla E, Caza TN, Clair B, Bartos A, Miklossy G, Jimah J, Doherty E, Tily H, Francis L, Garcia R, Dawood M, Yu J, Ramos I, Coman I, Faraone SV, Phillips PE, Perl A.
Lai ZW, et al. Among authors: dawood m.
Arthritis Rheum. 2012 Sep;64(9):2937-46. doi: 10.1002/art.34502.
Arthritis Rheum. 2012.
PMID: 22549432
Free PMC article.
Clinical Trial.